abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Esta página não está disponível em Português e está sendo exibida em English

Artigo

22 Abr 2024

Author:
Reuters

Africa: Johnson and Johnson alleged contaminated children cough syrup banned from shelves, incl. co. response

" Contaminated cough syrup in Africa no longer available - WHO" 22 April 2024

A contaminated batch of Benylin Paediatric Syrup is no longer available in the African countries where it was sold, the World Health Organization said on Monday. Earlier this month, Nigeria recalled a batch of the children's cough and allergy medicine after tests found that it contained unacceptable levels of the toxin, diethylene glycol. Five other African countries have also pulled the product from shelves - Kenya, Rwanda, Tanzania, Zimbabwe and South Africa, where the drug was made. The recalled batch of Benylin syrup was made by Johnson & Johnson (JNJ.N) in South Africa in May 2021, although Kenvue (KVUE.N) now owns the brand after a spin-off from J&J last year. J&J has referred requests for comment to Kenvue. In an emailed statement on Friday, Kenvue said it had carried out tests on the batch recalled by Nigeria and had not detected either diethylene or ethylene glycol, but was continuing to work with the authorities. Diethylene glycol can cause acute kidney failure and alongside another related toxin, ethylene glycol, has been linked to the deaths of more than 300 children in Cameroon, Gambia, Indonesia and Uzbekistan since 2022 after being found in medicines made in India and Indonesia. No children have been reported hurt or killed in the latest incident. The WHO, which has warned countries and companies to be vigilant about the ongoing risk of contamination, said on Friday it was "likely" to issue a broader alert about Benylin. However, on Monday the health agency said it no longer had immediate plans to do so after getting more information at the end of the week. "Considering that this batch is no longer on the market in any of the impacted countries and it has been consumed with no apparent reports of adverse effects, we believe that there is no immediate public health risk," a spokesperson said by email.

Privacy information

Este site usa cookies e outras tecnologias de armazenamento na web. Você pode definir suas opções de privacidade abaixo. As alterações entrarão em vigor imediatamente.

Para obter mais informações sobre nosso uso de armazenamento na web, consulte nossa Política de Uso de Dados e de Cookies

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

Cookies analíticos

ON
OFF

Quando você acessa nosso site, usamos o Google Analytics para coletar informações sobre sua visita. A aceitação deste cookie nos permitirá entender mais detalhes sobre sua viagem, e melhorar a forma como nós colocamos as informações na superfície. Todas as informações analíticas são anônimas e não as utilizamos para identificá-lo. O Google fornece uma opção de não inclusão no Google Analytics para todos os navegadores populares.

Cookies promocionais

ON
OFF

Compartilhamos notícias e atualizações sobre empresas e direitos humanos através de plataformas de terceiros, incluindo mídias sociais e mecanismos de busca. Estes cookies nos ajudam a entender o desempenho destas promoções.

Suas escolhas de privacidade para este site

Este site usa cookies e outras tecnologias de armazenamento da web para aprimorar sua experiência além da funcionalidade básica necessária.